Challenge: A leading biopharma company faced escalating CRO costs and inconsistent quality under a fully outsourced model. Leadership sought a more flexible sourcing strategy balancing internal capability with specialized partner engagement. Scimitar was engaged to redefine the sourcing vision, governance model, and partner selection criteria.
Approach: Through executive workshops and SME interviews, Scimitar benchmarked functional models, developed quantitative scoring tools, and mapped core versus external activities. The team produced a digital playbook, future-state process maps, and comprehensive cost modeling to guide the transition to a blended FSO–FSP–internal structure.
Impact: The new hybrid sourcing framework yielded 20% cost savings, accelerated internal capability builds, and strengthened vendor governance. Implementation plans were fully endorsed by executive leadership, establishing a scalable sourcing ecosystem with improved efficiency, accountability, and cross-functional transparency.
